Viewing Study NCT05362760

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-01-01 @ 10:31 AM
Study NCT ID: NCT05362760
Status: RECRUITING
Last Update Posted: 2025-05-16
First Post: 2022-04-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Sponsor: Prof. Wolfgang Janni
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone Receptor-positive Metastatic Breast Cancer View
None HER2-negative Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None hormone receptor-positive View
None HER2-negative View
None locally advanced/metastatic breast cancer View
None abemaciclib View
None endocrine therapy View
None phase IV View